Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study.

Mattioli I, Urban ML, Padoan R, Mohammad AJ, Salvarani C, Baldini C, Berti A, Cameli P, Caminati M, Cathébras P, Bianchi FC, Cinetto F, Cohen Tervaert JW, Coppola A, Costanzo G, Cottin V, Crimi C, Del Giacco S, Desaintjean C, Egan A, Espigol-Frigolé G, Folci M, Fornaro M, Franceschini F, Govoni M, Groh M, Guarnieri G, Hellmich B, Iannone F, Jones R, Kernder A, Lo Gullo A, Lombardi C, Lopalco G, Losappio L, Marchi MR, Rivera CM, Marvisi C, Maule M, Moi L, Monti S, Moosig F, Moroncini G, Negrini SM, Neumann T, Nolasco S, Novikov P, Roccatello D, Samson M, Schroeder JW, Seeliger B, Sinico RA, Solans R, Tcherakian C, Toniati P, Treppo E, Trivioli G, Vacca A, Jayne D, Bettiol A, Vaglio A, Emmi G, European EGPA Study Group

Open source

DOI: 10.1016/j.jaut.2025.103398
Published: 2025 May
Container: Journal of autoimmunity
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jaut.2025.103398,
  title = {Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study.},
  author = {Mattioli I and Urban ML and Padoan R and Mohammad AJ and Salvarani C and Baldini C and Berti A and Cameli P and Caminati M and Cathébras P and Bianchi FC and Cinetto F and Cohen Tervaert JW and Coppola A and Costanzo G and Cottin V and Crimi C and Del Giacco S and Desaintjean C and Egan A and Espigol-Frigolé G and Folci M and Fornaro M and Franceschini F and Govoni M and Groh M and Guarnieri G and Hellmich B and Iannone F and Jones R and Kernder A and Lo Gullo A and Lombardi C and Lopalco G and Losappio L and Marchi MR and Rivera CM and Marvisi C and Maule M and Moi L and Monti S and Moosig F and Moroncini G and Negrini SM and Neumann T and Nolasco S and Novikov P and Roccatello D and Samson M and Schroeder JW and Seeliger B and Sinico RA and Solans R and Tcherakian C and Toniati P and Treppo E and Trivioli G and Vacca A and Jayne D and Bettiol A and Vaglio A and Emmi G and European EGPA Study Group},
  year = {2025},
  journal = {Journal of autoimmunity},
  doi = {10.1016/j.jaut.2025.103398},
  url = {https://doi.org/10.1016/j.jaut.2025.103398}
}

RIS

TY  - JOUR
TI  - Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study.
AU  - Mattioli I
AU  - Urban ML
AU  - Padoan R
AU  - Mohammad AJ
AU  - Salvarani C
AU  - Baldini C
AU  - Berti A
AU  - Cameli P
AU  - Caminati M
AU  - Cathébras P
AU  - Bianchi FC
AU  - Cinetto F
AU  - Cohen Tervaert JW
AU  - Coppola A
AU  - Costanzo G
AU  - Cottin V
AU  - Crimi C
AU  - Del Giacco S
AU  - Desaintjean C
AU  - Egan A
AU  - Espigol-Frigolé G
AU  - Folci M
AU  - Fornaro M
AU  - Franceschini F
AU  - Govoni M
AU  - Groh M
AU  - Guarnieri G
AU  - Hellmich B
AU  - Iannone F
AU  - Jones R
AU  - Kernder A
AU  - Lo Gullo A
AU  - Lombardi C
AU  - Lopalco G
AU  - Losappio L
AU  - Marchi MR
AU  - Rivera CM
AU  - Marvisi C
AU  - Maule M
AU  - Moi L
AU  - Monti S
AU  - Moosig F
AU  - Moroncini G
AU  - Negrini SM
AU  - Neumann T
AU  - Nolasco S
AU  - Novikov P
AU  - Roccatello D
AU  - Samson M
AU  - Schroeder JW
AU  - Seeliger B
AU  - Sinico RA
AU  - Solans R
AU  - Tcherakian C
AU  - Toniati P
AU  - Treppo E
AU  - Trivioli G
AU  - Vacca A
AU  - Jayne D
AU  - Bettiol A
AU  - Vaglio A
AU  - Emmi G
AU  - European EGPA Study Group
PY  - 2025
JO  - Journal of autoimmunity
DO  - 10.1016/j.jaut.2025.103398
UR  - https://doi.org/10.1016/j.jaut.2025.103398
ER  -

APA

I, M., ML, U., R, P., AJ, M., C, S., C, B., A, B., P, C., M, C., P, C., FC, B., F, C., JW, C. T., A, C., G, C., V, C., C, C., S, D. G., C, D., A, E., G, E., M, F., M, F., F, F., M, G., M, G., G, G., B, H., F, I., R, J., A, K., A, L. G., C, L., G, L., L, L., MR, M., CM, R., C, M., M, M., L, M., S, M., F, M., G, M., SM, N., T, N., S, N., P, N., D, R., M, S., JW, S., B, S., RA, S., R, S., C, T., P, T., E, T., G, T., A, V., D, J., A, B., A, V., G, E., & Group, E. E. S. (2025). Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study.. Journal of autoimmunity. https://doi.org/10.1016/j.jaut.2025.103398

Source records

pubmed · retrieved 2026-09-27T10:14:17.424Z